2-(3-(4-Bromo-2-Fluorobenzyl)-4-Oxo-3,4-Dihydrophthalazin-1-Yl)Acetic Acid 2-(3-(4-溴-2-氟苄基)-4-氧代-3,4-二氢酞嗪-1-基)乙酸

CAS 72702-95-5 MFCD00204117

化学结构图

72702-95-5
SMILES: OC(=O)CC1=NN(CC2=CC=C(Br)C=C2F)C(=O)C2C=CC=CC1=2

化学属性

Mol. FormulaC17H12BrFN2O3
Mol. Weight391.195

别名和识别编码

Chemical Name2-(3-(4-Bromo-2-Fluorobenzyl)-4-Oxo-3,4-Dihydrophthalazin-1-Yl)Acetic Acid
Chemical Name Translation2-(3-(4-溴-2-氟苄基)-4-氧代-3,4-二氢酞嗪-1-基)乙酸
信息真实价格透明    资金保障    专业采购外包团队在线服务   
信息真实价格透明    资金保障    专业采购外包团队在线服务   
品牌质保精细包装    现货库存    一流品牌服务   

相关文献及参考

  • [2]. Bresson E, et al. The human aldose reductase AKR1B1 qualifies as the primary prostaglandin F synthase in the endometrium. J Clin Endocrinol Metab. 2011 Jan;96(1):210-9.
  • [3]. Calcutt NA, et al. Prevention of sensory disorders in diabetic Sprague-Dawley rats by aldose reductase inhibition or treatment with ciliary neurotrophic factor. Diabetologia. 2004 Apr;47(4):718-24.
  • [1]. Ward WH, et al. Ponalrestat: a potent and specific inhibitor of aldose reductase. Biochem Pharmacol. 1990 Jan 15;39(2):337-46.
  • [1]. Ward WH, et al. Ponalrestat: a potent and specific inhibitor of aldose reductase. Biochem Pharmacol. 1990 Jan 15;39(2):337-46.
  • [2]. Bresson E, et al. The human aldose reductase AKR1B1 qualifies as the primary prostaglandin F synthase in the endometrium. J Clin Endocrinol Metab. 2011 Jan;96(1):210-9.
  • [3]. Calcutt NA, et al. Prevention of sensory disorders in diabetic Sprague-Dawley rats by aldose reductase inhibition or treatment wi

系列性分类

  1. Chemical Synthesis 化学合成
  2. Building Blocks 合成砌块
  3. Chemicals by Class 化学分类法
  4. Halogenated 卤化物 (氟氯溴碘)
  5. Fluoro 氟化物
  1. Medical Research Areas
  2. Metabolism
  3. Aldose Reductase  (醛糖还原酶)

相关产品推荐